Nipro Diagnostics, Inc. Purchases New Building, Expands Fort Lauderdale Operations; Creating New Jobs

Published: Jan 26, 2012

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Nipro Diagnostics, Inc., a leading manufacturer and marketer of blood glucose monitoring products and supplies for diabetes management, has purchased a new corporate headquarters facility in Fort Lauderdale to house many of the company’s operations. The building, located at 2200 West Cypress Creek Road in Fort Lauderdale, will serve as global headquarters for the executive team, marketing, finance, operations, accounting, R&D, regulatory, and human resources of Nipro Diagnostics. Manufacturing will continue to take place at the company’s facility at NW 55th Court in Fort Lauderdale, purchased in December 2011.

“This new corporate headquarters complex of almost 80,000 square feet, located on seven acres, affords us the space and capabilities to grow our business and keep up with increasing demand for our products,” said Scott Verner, President and CEO of Nipro Diagnostics. “Just as we’re dedicated to providing high quality and affordable diabetes care products, we’re committed to Fort Lauderdale, expanding our operations here and creating new jobs.” It is anticipated that Nipro Diagnostics’ operations will move to the new building in the second quarter of 2012. This is the third building Nipro Diagnostics has acquired in the last six months.

The announcement of this new facility comes shortly after Nipro Diagnostics was named 2011 Manufacturer of the Year by the Manufacturers Association of Florida in the large-company (500+ employee) category in December 2011. The company’s TRUEresult® and TRUE2go®Blood Glucose Monitors were also recently awarded ratings of “recommended” by a leading consumer magazine, achieving scores superior to those of many higher priced, nationally-brand meters. Nipro Diagnostics manufactures blood glucose monitors that are co-branded under the names of leading pharmacy chains and distributors.

About Nipro Diagnostics, Inc.

Based in Fort Lauderdale, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes management products. The company offers a portfolio of high quality blood glucose monitoring systems and products available around the world.

Nipro Diagnostics is the exclusive supplier of blood glucose monitoring systems, co-branded under the TRUE name, for leading pharmacies including CVS, Rite Aid, Walgreens and Wegmans; as well as for distributors such as AmerisourceBergen, Cardinal Health, McKesson, Invacare and Liberty Medical. For more information, please visit


Nipro Diagnostics, Inc.

Lisa Nardi, 800-342-7226, ext. 2183

Vice President, Marketing

Back to news